Filing Details

Accession Number:
0001567619-20-012520
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-23 19:24:57
Reporting Period:
2020-04-30
Accepted Time:
2020-06-23 19:24:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557533 Robert Jeffrey Ajer C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Evp, Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-30 338 $62.59 63,402 No 5 A Direct
Common Stock Acquisiton 2020-06-19 15,000 $63.10 78,402 No 4 M Direct
Common Stock Disposition 2020-06-19 15,000 $124.00 63,402 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy Common Stock) Disposition 2020-06-19 15,000 $0.00 15,000 $63.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,700 2014-12-04 2024-06-03 No 4 M Direct
Footnotes
  1. Represents shares acquired by the reporting person on April 30, 2020, pursuant to the issuer's Employee Stock Purchase Plan.
  2. Trade made pursuant to a 10b5-1 plan executed on December 20, 2019.
  3. Reflects the number of options outstanding after the transactions from this specific stock option grant.